Rachael Gakii Murithi | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Rachael Gakii Murithi
Tsinghua University, China

Rachael Gakii Murithi
Affiliation Tsinghua University
Country China
Scopus ID 57221382349
Documents 5
Citations 73
h-index 5
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0002-6653-3833

The Innovative Research Award recognizes the scholarly contributions of Rachael Gakii Murithi in the interdisciplinary fields of public health, maternal survival studies, environmental exposure analysis, and global health inequality research. Her academic work at Tsinghua University reflects a research-oriented approach focused on evidence-based health analysis, comparative international studies, and systematic reviews addressing vulnerable populations. Her publications contribute to contemporary discourse surrounding maternal mortality, gender inequality, indoor pollution exposure, and health disparities in low- and middle-income countries.[1]

Abstract

Rachael Gakii Murithi has contributed to emerging research discussions within medicine and health sciences through publications examining maternal mortality, environmental pollutants, gender inequality, and adolescent fertility indicators. Her scholarly output integrates quantitative health analysis with comparative global datasets to evaluate structural determinants influencing health outcomes across developing regions.[2]

Keywords

Maternal mortality, global health inequality, adolescent fertility, indoor pollutants, neurodevelopmental disorders, environmental health, public health analytics, comparative health studies.

Introduction

Contemporary health science increasingly emphasizes interdisciplinary methodologies to address inequalities in healthcare access and population health outcomes. Murithi’s work contributes to this framework by examining maternal survival disparities, exposure to airborne pollutants, and sociopolitical determinants of gender inequality across multiple regions.[3] Her studies utilize comparative analyses, systematic review methods, and public health indicators to interpret global health trends.

Research Profile

Murithi’s academic profile includes publications indexed through recognized scholarly databases and citation platforms. Her research interests focus on maternal health, environmental risk assessment, adolescent fertility patterns, and social determinants affecting vulnerable populations. The integration of statistical modeling with comparative international data has enabled her work to address multidimensional public health concerns.[4]

Research Contributions

  • Conducted comparative cluster analyses examining maternal survival inequalities across 49 Sub-Saharan African countries.
  • Investigated adolescent birth rates and female education as determinants of maternal mortality disparities in low- and middle-income countries.
  • Published systematic reviews on indoor pollutants and their association with respiratory, neurodevelopmental, and oncological risks.
  • Explored structural drivers of gender inequality, including fertility patterns and political representation.

Publications

  • Inequality and maternal survival cluster analysis of 49 Sub Saharan countries (2026).
  • Plastic mulching drives microplastic accumulation and redistribution in arid agroecosystems (2026).
  • Adolescent Birth Rates and Female Education Drive Maternal Mortality Disparities in Low- and Middle-Income Countries (2026).

Research Impact

Murithi’s research output has contributed to scholarly discussions surrounding public health inequality and environmental health exposure. Citation metrics indicate academic engagement with her work in areas related to maternal health and environmental risk analysis. Her studies also support policy-oriented discussions concerning education, reproductive health, and pollution-related health outcomes in vulnerable populations.[5]

Award Suitability

The Innovative Research Award acknowledges scholarly contributions demonstrating interdisciplinary relevance, methodological rigor, and measurable academic impact. Murithi’s research portfolio aligns with these criteria through investigations addressing global maternal health disparities, environmental exposure risks, and gender-related public health indicators. Her work reflects ongoing engagement with contemporary healthcare challenges and data-driven research methodologies.[6]

Conclusion

Rachael Gakii Murithi’s academic contributions within medicine and health sciences demonstrate a sustained focus on global health inequality, environmental exposure analysis, and maternal survival research. Through comparative studies, systematic reviews, and interdisciplinary public health investigations, her work contributes to evidence-based understanding of health disparities affecting diverse populations worldwide.

References

  1. Elsevier. (n.d.). Scopus author details: Rachael Gakii Murithi, Author ID 57221382349. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57221382349
  2. Murithi, R. G. (2026). Inequality and maternal survival cluster analysis of 49 Sub Saharan countries. Discover Public Health.
    https://doi.org/10.1186/s12982-026-02069-9
  3. Murithi, R. G. (2026). Adolescent Birth Rates and Female Education Drive Maternal Mortality Disparities in Low- and Middle-Income Countries.
    https://doi.org/10.33140/japm.11.01.01
  4. Murithi, R. G. (2025). Prenatal Exposure to Airborne and Indoor Pollutants and the Risk of Childhood Neurodevelopmental Disorders.
    https://doi.org/10.33140/japm.10.03.02
  5. Murithi, R. G. (2025). Associations between Indoor Pollutants, Neurodevelopmental, Oncological, and Respiratory Health Risks, and Vulnerable Populations: A Systematic Review.
    https://doi.org/10.21203/rs.3.rs-7440867/v1
  6. International Forensic Scientist Awards. (n.d.). Award recognition and academic excellence platform.
    forensicscientist.org

Yury Kustov | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Best Researcher Award

Yury Kustov
Peoples’ Friendship University of Russia
Yury Kustov
Affiliation Peoples’ Friendship University of Russia
Country Russia
Scopus ID 58987836800
Documents 5
Citations 4
h-index 1
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0009-0002-4859-4322

Yury Kustov is a researcher affiliated with the Peoples’ Friendship University of Russia whose scholarly work focuses on medicine, pharmacovigilance, drug safety, pulmonary fibrosis, and clinical pharmacology. His recent publications examine adverse drug reactions, pediatric pharmacotherapy, pulmonary complications, and systematic reviews related to pharmacokinetics and post-COVID-19 outcomes. Through contributions indexed in Scopus, Kustov has participated in interdisciplinary investigations concerning patient safety and evidence-based medical analysis.[1] His profile reflects active engagement in healthcare-related research areas associated with pharmacological monitoring and clinical risk assessment.[2]

Abstract

The academic contributions of Yury Kustov are associated with contemporary clinical medicine and pharmacovigilance research. His published studies explore adverse drug reactions, pulmonary fibrosis, antibiotic safety, and pediatric therapeutic outcomes. Several investigations emphasize spontaneous report database analysis and systematic reviews in order to improve healthcare monitoring and pharmacological safety standards.[3] These contributions support broader scientific discussions regarding medication-related complications and patient-centered clinical evaluation.

Keywords

Pharmacovigilance, Clinical Pharmacology, Pulmonary Fibrosis, Pediatric Medicine, Drug Safety, Post-COVID Research, Pharmacokinetics, Medicine and Health Sciences.

Introduction

The advancement of modern healthcare increasingly depends on pharmacological safety assessment and evidence-based therapeutic monitoring. Researchers involved in pharmacovigilance contribute to the identification of adverse reactions and clinical complications linked to pharmaceutical interventions. Yury Kustov has participated in this research landscape through studies addressing antibacterial drug reactions, pulmonary fibrosis, and pediatric medicine.[4] His publications demonstrate engagement with healthcare datasets and clinical literature reviews that contribute to scientific understanding of treatment-related risks.

Research Profile

Kustov’s academic profile includes journal articles and conference publications indexed through Scopus and related scholarly databases. His research areas include pharmacokinetics in chronic heart failure, pulmonary fibrosis associated with pharmacotherapy, and pediatric antibacterial drug safety. The researcher has also examined Stevens–Johnson syndrome and toxic epidermal necrolysis using spontaneous reporting systems.[5] These studies align with medical efforts to improve treatment evaluation and patient safety methodologies.

Research Contributions

  • Analysis of fluoroquinolone safety in pediatric populations through pharmacovigilance database studies.
  • Systematic review research concerning pharmacokinetic alterations in chronic heart failure patients.
  • Investigations into pulmonary fibrosis and post-COVID-19 pharmacotherapy outcomes.
  • Evaluation of spontaneous adverse drug reaction reports linked to antibacterial medications.

Publications

  • “Safety of fluoroquinolones in pediatric patients: Pharmacovigilance database analysis”
  • “Pharmacokinetic Alterations in Patients with Chronic Heart Failure: A Systematic Review”
  • “Drug-Induced Pulmonary Fibrosis: National Database Analysis”

Research Impact

The research contributions of Yury Kustov demonstrate relevance to healthcare monitoring, medication safety assessment, and evidence-based pharmacology. By utilizing systematic reviews and spontaneous report analyses, his studies contribute to discussions surrounding adverse drug reaction surveillance and therapeutic evaluation. Such research supports clinicians, pharmacologists, and healthcare researchers seeking to understand treatment-related complications in vulnerable patient populations.

Award Suitability

Yury Kustov’s publication record and involvement in pharmacovigilance-related medical studies align with the objectives of the International Forensic Scientist Awards. His focus on drug safety analysis, pulmonary complications, and healthcare risk assessment reflects scholarly engagement with medically significant challenges. The integration of database-driven clinical analysis and systematic review methodologies further demonstrates research activity associated with modern healthcare science and patient protection initiatives.

Conclusion

Yury Kustov has contributed to medicine and health sciences through publications examining pharmacovigilance, pulmonary fibrosis, clinical pharmacology, and pediatric drug safety. His academic profile reflects ongoing participation in evidence-based medical research and healthcare monitoring studies. Through indexed scholarly outputs and DOI-linked publications, his work contributes to the broader scientific understanding of pharmaceutical safety and patient-centered clinical investigation.

References

  1. Elsevier. (n.d.). Scopus author details: Yury Kustov, Author ID 58987836800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58987836800
  2. ORCID. (n.d.). Yury Kustov ORCID profile.
    https://orcid.org/0009-0002-4859-4322
  3. Kustov, Y. (2026). Safety of fluoroquinolones in pediatric patients: Pharmacovigilance database analysis.
    https://doi.org/10.1177/09246479251398995
  4. Kustov, Y. (2025). Pharmacokinetic Alterations in Patients with Chronic Heart Failure: A Systematic Review.
    https://doi.org/10.3390/ijms26199495
  5. Kustov, Y. (2024). Drug-Induced Pulmonary Fibrosis: National Database Analysis.
    https://doi.org/10.3390/biomedicines12122650

Hong Zhang | Medicine and Health Sciences | Innovative Research Award

Published on by Forensic Scientist Awards

Innovative Research Award

Hong Zhang
University of Texas Southwestern Medical Center, United States
Hong Zhang
Affiliation University of Texas Southwestern Medical Center
Country United States
Scopus ID 57192482890
Documents 28
Citations 550
h-index 13
Subject Area Medicine and Health Sciences
Event International Forensic Scientist Awards
ORCID 0000-0003-3056-0343

Hong Zhang, is an orthopedic surgeon, biomedical innovator, and musculoskeletal research specialist affiliated with the University of Texas Southwestern Medical Center and Texas Scottish Rite Hospital for Children in Dallas, Texas. His research activities focus primarily on pediatric spinal deformities, growth modulation, spinal instrumentation development, scoliosis correction technologies, and minimally invasive spinal surgery. Through a combination of clinical orthopedic expertise and translational biomedical engineering, Zhang has contributed to the development of novel surgical systems and patented technologies intended to improve the treatment of severe spinal deformities and early-onset scoliosis.[1]

As Director of the Division of Creative Innovations within the Seay Center for Musculoskeletal Research, Zhang has overseen multidisciplinary investigations involving experimental spine biomechanics, orthopedic implant design, pediatric spine growth modulation, and surgical correction strategies. His publication record, citation metrics, and patent portfolio demonstrate sustained scholarly engagement in orthopedic research and spinal deformity innovation.[2]

Abstract

Hong Zhang is recognized for contributions to orthopedic surgery research, spinal deformity correction technologies, and pediatric musculoskeletal innovation. His work has focused on improving surgical outcomes for severe scoliosis and kyphosis through biomechanical research, implant design, and translational clinical investigations. Zhang has also contributed to orthopedic device development through multiple United States patents related to spinal correction systems and stabilization technologies.[3] His scholarly publications in journals such as Spine Deformity, European Spine Journal, and Seminars in Spine Surgery highlight continued engagement in experimental spine research and orthopedic innovation.[4]

Keywords

Orthopedic Surgery, Pediatric Scoliosis, Spinal Deformity, Spine Research, Musculoskeletal Innovation, Early-Onset Scoliosis, Orthopedic Instrumentation, Growth Modulation, Biomedical Engineering, Pediatric Orthopedics

Introduction

The field of pediatric spinal deformity research requires coordinated advances in biomechanics, surgical techniques, implant engineering, and long-term clinical evaluation. Hong Zhang has contributed to this interdisciplinary area through research addressing early-onset scoliosis, thoracic deformities, vertebral correction systems, and growth-preserving spinal interventions. His investigations combine experimental orthopedic science with clinically applicable instrumentation design.[5]

Zhang obtained his medical degree from Tianjin Medical University in China and completed orthopedic surgery training at Tianjin Hospital before undertaking international orthopedic research and clinical scholarship programs in Italy and the United States. Since joining the University of Texas Southwestern Medical Center and Texas Scottish Rite Hospital for Children, he has participated in numerous collaborative orthopedic research initiatives focused on pediatric spine disorders and surgical innovation.[6]

Research Profile

Hong Zhang currently serves as Director of the Division of Creative Innovations within the Center of Excellence in Spine Research at the Seay Center for Musculoskeletal Research, Texas Scottish Rite Hospital for Children, Dallas, Texas. He also holds the academic position of Associate Professor in the Department of Orthopaedic Surgery at the University of Texas Southwestern Medical Center.[1]

His research profile demonstrates sustained focus on pediatric spinal deformities, including early-onset scoliosis, thoracic kyphosis, spinal growth modulation systems, minimally invasive thoracoscopic procedures, and spinal instrumentation biomechanics. Zhang’s work frequently integrates engineering methodologies, experimental spine models, and translational orthopedic device development.[7]

  • Early-onset scoliosis and pediatric spine growth research
  • Orthopedic implant and spinal instrumentation development
  • Growth modulation systems for spinal correction
  • Biomechanical evaluation of spinal deformity devices
  • Experimental and translational musculoskeletal research
  • Minimally invasive spinal surgical technologies

Research Contributions

Zhang has contributed extensively to the development of innovative spinal correction systems intended for severe spinal deformities and pediatric scoliosis treatment. His patented orthopedic technologies include spinal rod reduction devices, pedicle screw systems, stabilization fasteners, and hinge-link spinal correction devices designed to improve alignment control and surgical correction efficiency.[8]

A significant component of his recent research involves the development of growth modulation systems using dynamic spinal correction approaches. Experimental investigations involving porcine models and three-dimensional simulation technologies have supported the evaluation of biomechanical effectiveness and safety profiles of novel correction systems.[9]

Zhang’s work on vertebral column resection systems and angular kyphosis reduction devices has also contributed to understanding correction strategies for severe thoracic spinal deformities. These studies have explored both implant mechanics and surgical feasibility in complex deformity correction procedures.[10]

  • Development of hinge-link spinal correction technologies
  • Novel uniplanar correction systems for angular kyphosis
  • Dynamic scoliosis correction and growth modulation research
  • Biomechanical studies of pediatric spinal instrumentation
  • Experimental orthopedic implant design and testing

Publications

Hong Zhang has authored and co-authored multiple peer-reviewed scientific publications addressing pediatric scoliosis, thoracic deformity correction, spine biomechanics, and orthopedic surgical technologies.[11]

  1. Zhang H, Lima JM, Jo CH, and Sucato DJ. The closing triradiate cartilage stage identifies accelerated curve progression in idiopathic scoliosis. Spine Deformity (2026).
  2. Zhang H, Ross D, and Sucato DJ. Evaluation of a novel angular kyphosis reduction device for vertebral column resection in severe angular kyphosis. European Journal of Orthopaedic Surgery & Traumatology (2026).
  3. Zhang H, Ross D, and Sucato DJ. A new uniplanar correction strategy for severe thoracic kyphosis: concept, device design, and simulation with a 3D-printed model. Spine Deformity (2026).
  4. Zhang H, Niese B, and Sucato DJ. Growth modulation and dynamic correction of early-onset thoracic scoliosis using a PEEK spring rib plate system: a porcine model study. Spine Deformity (2026).
  5. Brooks JT, Carron CJ, Zhang H, and Sucato DJ. Going anterior for the surgical management of pediatric scoliosis: Indications and technique pearls. Seminars in Spine Surgery (2025).

Research Impact

According to available Scopus metrics, Zhang has produced 28 indexed scholarly documents with approximately 550 citations and an h-index of 13, reflecting measurable academic influence within orthopedic surgery and musculoskeletal research communities.[1] His research output has contributed to the scientific understanding of pediatric spinal deformities, spinal growth dynamics, and orthopedic implant biomechanics.

His work has also received recognition through national and international awards, including the John H. Moe Award for Best Basic Science presented by the Scoliosis Research Society in both 2009 and 2010.[12] Additional grant support from organizations such as the Pediatric Orthopedic Society of North America and the Scoliosis Research Society further reflects the relevance of his investigations within pediatric orthopedic research.

Award Suitability

Hong Zhang’s academic profile aligns with the objectives of the Innovative Research Award due to his sustained contributions to orthopedic surgery innovation, spinal deformity correction technologies, and translational pediatric spine research. His work demonstrates interdisciplinary integration between clinical orthopedic practice, biomechanical engineering, and experimental medical device development.[8]

The combination of peer-reviewed publications, patented surgical systems, funded research projects, and international scientific recognition supports consideration of Zhang’s contributions within the field of medicine and health sciences. His focus on improving treatment strategies for complex pediatric spinal conditions reflects ongoing commitment to clinically relevant biomedical innovation.[10]

Conclusion

Hong Zhang has established a scholarly and clinical research profile centered on pediatric orthopedic innovation and spinal deformity correction. Through collaborative orthopedic research, patented instrumentation systems, and translational experimental studies, he has contributed to the advancement of spinal surgery technologies and pediatric musculoskeletal care. His publication history, research awards, and scientific contributions collectively support recognition within international academic and biomedical innovation platforms.[11]

References

  1. Elsevier. (n.d.). Scopus author details: Hong Zhang, Author ID 57192482890. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57192482890
  2. University of Texas Southwestern Medical Center. (n.d.). Faculty and research profile information for Hong Zhang.
  3. United States Patent and Trademark Office. (2010). Method for the Correction of Spinal Deformities Using Rod-Plate Anterior System.
  4. Springer Nature. (2026). Spine Deformity journal publications authored by Hong Zhang.
  5. Zhang H, Ross D, and Sucato DJ. (2026). Evaluation of a novel angular kyphosis reduction device for vertebral column resection in severe angular kyphosis.
    https://doi.org/10.1007/s00590-026-04778-y
  6. Texas Scottish Rite Hospital for Children. (n.d.). Seay Center for Musculoskeletal Research profile.
  7. Zhang H, Niese B, and Sucato DJ. (2026). Growth modulation and dynamic correction of early-onset thoracic scoliosis using a PEEK spring rib plate system.
    https://doi.org/10.1007/s43390-026-01284-3
  8. United States Patent and Trademark Office. (2023). Hinge-Link Spinal Correction Device and Method.
  9. Wang XB, Zhang H, and Sucato DJ. (2023). Unilateral thoracic spinal nerve resection creates early onset thoracic scoliosis in an immature porcine model.
    https://doi.org/10.1007/s00586-023-07804-3
  10. Zhang H, Ross D, and Sucato DJ. (2024). A Novel Uniplanar Clamp-Hinge Correction System for Vertebral Column Resection of Severe Angular Kyphosis.
    https://doi.org/10.1007/s43390-023-00770-2
  11. Elsevier. (n.d.). Publication and citation metrics for Hong Zhang in orthopedic research.
  12. Scoliosis Research Society. (2010). John H. Moe Award for Best Basic Science.

Fulya Erendor Cihan | Medicine and Health Sciences | Best Review Paper Award

Published on by Forensic Scientist Awards

Assist. Prof. Dr. Fulya Erendor Cihan | Medicine and Health Sciences | Best Review Paper Award

Ordu University | Turkey

Dr. Fulya Erendor Cihan is an emerging researcher in gene and cell therapy, with a strong focus on precision gene editing, viral vector systems, and therapeutic strategies for metabolic and neurodegenerative diseases. Her work integrates advanced molecular biology techniques with translational research, particularly in diabetes, COVID-19 vaccine development, and neuroprotection. She has contributed to multiple nationally funded research projects and international collaborations, emphasizing lentiviral and adenoviral vector-based therapies. Her research outputs include high-impact journal publications, conference proceedings, and book chapters, reflecting her growing influence in biomedical innovation and experimental therapeutics.

                        Citation Metrics (Google Scholar)

300

250

200

150

100

50

0

 

Citations
150
Documents
25
h-index
5

Citations

Documents

h-index

View Google Scholar Profile  View ORCID Profile

Featured Publications


Gene and cell therapy of human genetic diseases: Recent advances and future directions

– Journal of Cellular and Molecular Medicine, 2024 | Cited by: 33

Xuefei Wang | Medicine and Health Sciences | Research Excellence Award

Published on by Forensic Scientist Awards

Prof. Xuefei Wang | Medicine and Health Sciences | Research Excellence Award

Zhongshan Hospital, Fudan University | China

Prof. Xuefei Wang is a leading researcher in gastric cancer biology and translational oncology, with over 100 peer-reviewed publications and significant citation impact. His work focuses on molecular mechanisms of tumor metastasis, DNA damage repair, and chemoradiotherapy resistance. He has contributed to high-impact journals such as Cell Death & Differentiation and Advanced Science. His research integrates CRISPR-based functional genomics, post-translational modifications, and targeted therapeutic development. He is actively involved in multi-institutional collaborations and serves as a reviewer for international SCI journals. His innovations include peptide-based therapeutic strategies targeting cancer resistance pathways.

View ORCID Profile  View ResearchGate Profile

Featured Publications

Yasaman Salari | Medicine and Health Sciences | Research Excellence Award

Published on by Forensic Scientist Awards

Dr. Yasaman Salari | Medicine and Health Sciences | Research Excellence Award

University Hospitals Sussex | United Kingdom

Dr. Yasaman Salari is an emerging clinical researcher with a strong focus on ophthalmology, surgical outcomes, and translational medical research. Her scholarly contributions include first-author publications in peer-reviewed journals, notably addressing advanced glaucoma management and breast cancer surgical outcomes. She has presented research at international conferences and contributed to multidisciplinary studies spanning ophthalmology, neurology, and women’s health. Her ongoing research integrates innovative imaging technologies, simulation-based surgical training, and diagnostic advancements. Dr. Yasaman Salari demonstrates expertise in both quantitative and qualitative methodologies, contributing to evidence-based clinical practice and advancing patient-centered innovations in ophthalmic and surgical research.

                            Citation Metrics (Scopus)

6

5

4

3

2

1

0

 

Citations
0
Documents
2
h-index
0

Citations

Documents

h-index

View Scopus Profile  View ORCID Profile

Featured Publications

Gabriella Gould | Medicine and Health Sciences | Research Excellence Award

Published on by Forensic Scientist Awards

Ms. Gabriella Gould | Medicine and Health Sciences | Research Excellence Award

Bond University | Australia

Ms. Gabriella Gould is a dedicated physiotherapist and researcher with a focused expertise in musculoskeletal and vestibular physiotherapy, emphasizing evidence-based clinical assessment and rehabilitation strategies. Her research endeavors explore the diagnostic and therapeutic applications of physiotherapy interventions, with a particular emphasis on musculoskeletal conditions such as rotator cuff tendinopathy. Ms. Gabriella Gould’s most notable contribution is her systematic review on the use of diagnostic ultrasound for assessing rotator cuff tendinopathy, published in Ultrasound in Medicine & Biology. This work rigorously synthesizes current methodologies, highlighting both the strengths and limitations of ultrasound as a clinical assessment tool, and provides clinicians with clear, evidence-based guidance for improved diagnostic accuracy. Her research approach integrates clinical insights with scientific rigor, bridging the gap between research evidence and practical physiotherapy applications. In addition to her publications, Ms. Gabriella Gould actively engages with the broader research community through professional memberships, contributing to the development of standardized assessment protocols and evidence-informed practice guidelines. Her research contributions extend to promoting patient-centered care by ensuring that diagnostic and rehabilitation strategies are both effective and accessible. By combining innovative research, systematic evidence evaluation, and a commitment to translational application, Gabriella Gould’s work not only enhances the scientific understanding of musculoskeletal assessment but also drives improvements in clinical practice, optimizing patient outcomes. Her ongoing research interests continue to focus on advancing diagnostic precision, validating therapeutic interventions, and supporting the integration of emerging technologies into physiotherapy practice, establishing her as a rising contributor to evidence-based musculoskeletal and vestibular physiotherapy research.

Profiles: ORCID | LinkedIn

Featured Publication

Gould, G., Macindoe, C., Wong, J., & Matthews, W. (2025). The use of diagnostic ultrasound for the assessment of rotator cuff tendinopathy: A systematic review. Ultrasound in Medicine & Biology.

Yongxiang Wang | Pharmacology, Toxicology and Pharmaceutical Science | Research Excellence Award

Published on by Forensic Scientist Awards

Prof. Yongxiang Wang | Pharmacology, Toxicology and Pharmaceutical Science | Research Excellence Award

Shanghai Jiao Tong University | China

Prof. Yong-xiang Wang is an internationally recognized researcher in pain biology, neuropharmacology, and analgesic drug discovery, widely known for his pioneering contributions to molecular pain mechanisms, microglial signaling pathways, and therapeutic modulation of neuropathic hypersensitivity. His work has significantly advanced the understanding of spinal glucagon-like peptide-1 (GLP-1) receptor signaling, β-endorphin–mediated analgesic pathways, dynorphin A regulation, and microglial involvement in chronic pain modulation. With 104 Scopus-indexed research documents, 3,704 citations from 2,471 citing documents, and an h-index of 39, his scientific influence is firmly established across the global pain research community. His high-impact publications in leading journals such as Brain, Behavior, and Immunity, Journal of Neuroscience, British Journal of Pharmacology, Neuropharmacology, Pharmacological Research, and Anesthesiology highlight landmark discoveries in microglial IL-10 signaling, MAPK-associated inflammatory regulation, glucocorticoid receptor–mediated analgesia, and novel analgesic compounds derived from traditional herbal medicines. His extensive research portfolio encompasses neuropathic pain mechanisms, microglial cAMP/PKA/MAPK signaling pathways, reverse pharmacology of herbal analgesics, and systematic identification of novel analgesic molecules with translational therapeutic potential. Prof. Yong-xiang Wang has contributed to innovative patents in analgesic research, and his findings continue to shape emerging strategies in neuroimmune pain modulation. In addition to his scientific contributions, he provides editorial leadership for international journals, offers extensive peer-review service, and collaborates widely across the neuropharmacology field. His work has earned notable recognition through competitive research awards, high citation visibility, and sustained impact on the development of next-generation analgesic therapeutics.

Profile: Scopus

Featured Publications

1. Ma, L., Wei, J., Deng, M. Y., Ahmad, K. A., Huang, J., Zhao, M. J., Li, X., Mao, Y., Wang, Y.-X., & Chen, J. (2025). Spinal microglial membrane glucocorticoid receptors regulate anti-hypersensitivity by stimulating dynorphin A expression. European Journal of Pharmacology, 178362.

2. Deng, M. Y., Cheng, J., Gao, N., Li, X. Y., Liu, H., & Wang, Y.-X. (2024). Dexamethasone attenuates neuropathic pain through spinal microglial expression of dynorphin A via the cAMP/PKA/p38 MAPK/CREB signaling pathway. Brain, Behavior, and Immunity, 119, 36–50.

3. Shoaib, R. M., Ahmad, K. A., & Wang, Y.-X. (2021). Protopanaxadiol alleviates neuropathic pain by spinal microglial dynorphin A expression following glucocorticoid receptor activation. British Journal of Pharmacology, 178(15), 2976–2997.

4. Huang, Q., Mao, X.-F., Wu, H.-Y., Liu, H., Sun, M.-L., Wang, X., & Wang, Y.-X. (2017). Cynandione A attenuates neuropathic pain through p38β MAPK-mediated spinal microglial expression of β-endorphin. Brain, Behavior, and Immunity, 62, 64–77.

5. Xu, M., Wu, H.-Y., Liu, H., Gong, N., Wang, Y.-R., & Wang, Y.-X. (2017). Morroniside, a secoiridoid glycoside from Cornus officinalis, attenuates neuropathic pain by activation of spinal glucagon-like peptide-1 receptors. British Journal of Pharmacology, 174, 580–590.

Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Published on by Forensic Scientist Awards

Dr. Rama Ayash | Medicine and Health Sciences | Best Researcher Award

Damascus University | Syria

Dr. Rama Ayash is a medical advisor, senior lecturer, and scientific researcher specializing in clinical biochemistry, diabetes research, and molecular mechanisms of β-cell apoptosis. Her primary research focuses on the pathophysiological role of cytokines and death receptors in glucose dysregulation and prediabetes, with particular emphasis on the therapeutic effects of DPP4 inhibitors such as sitagliptin. Her recent publications include groundbreaking studies in Scientific Reports, BMC Endocrine Disorders, and the European Journal of Pharmacology, exploring inflammatory cytokine modulation, apoptotic biomarkers (FAS, TNFR1, TRAIL-R2), and their relationship to β-cell dysfunction. Dr. Rama Ayash’s research contributions advance understanding of early diabetic mechanisms, aiding in the development of targeted therapeutic strategies to preserve pancreatic function. She has also supervised diverse clinical and molecular research projects in cardiovascular pharmacology, endocrine biomarkers, and celiac disease diagnostics, demonstrating her interdisciplinary expertise. Her work integrates clinical biochemistry, molecular diagnostics, and translational medicine, contributing to the growing field of preventive and precision diabetology. Dr. Rama Ayash has been an active conference speaker and scientific presenter, sharing insights on cardio-renal pharmacology, metabolic pathways, and biomarker discovery. Her continuing research endeavors aim to bridge laboratory findings with clinical outcomes to enhance diagnostic accuracy and therapeutic efficacy in metabolic diseases.

Profiles: Google Scholar | ORCID

Featured Publications

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Exploring the predictive potentials of IL-1β and TNFR1 in atherogenic risk in prediabetes. Scientific Reports, 15(1), 37369. https://doi.org/10.1038/s41598-025-37369

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Association of soluble apoptotic biomarkers (FAS, TNFR1 and TRAIL-R2) with β-cell dysfunction in early glucose dysregulation. BMC Endocrine Disorders, 25(1), 218. https://doi.org/10.1186/s12902-025-0218

• Ayash, R., Kabalan, Y., & Chamaa, S. (2025). Sitagliptin reduces cytokine-induced β-cell apoptosis in prediabetes: A six-month interventional study. European Journal of Pharmacology, 177708. https://doi.org/10.1016/j.ejphar.2025.177708

Tuncay Kiris | Medicine and Health Sciences | Forensic Scientist of the Year Award

Published on by Forensic Scientist Awards

Assoc. Prof. Dr. Tuncay Kiris | Medicine and Health Sciences | Forensic Scientist of the Year Award

Izmir Katip Çelebi University Atatürk Training and Research Hospital | Turkey

Dr. Tuncay Kırış, an Associate Professor at İzmir Kâtip Çelebi University, Izmir, Turkey, is a distinguished cardiology researcher recognized for his extensive contributions to cardiovascular medicine, particularly in the fields of cardiovascular risk prediction, interventional cardiology, acute coronary syndromes, and cardiac biomarkers. His research has provided valuable insights into myocardial infarction, pulmonary embolism, renal complications following cardiac interventions, and the prognostic implications of biochemical and hematological markers in predicting patient outcomes. Dr. Tuncay Kırış has authored 83 peer-reviewed publications in prestigious international journals indexed in SCI and SCI-Expanded, including Angiology, BMC Cardiovascular Disorders, The Anatolian Journal of Cardiology, Clinical and Experimental Hypertension, Herz, and Acta Radiologica. His works have received 591 citations from 544 documents, with an h-index of 15, according to Scopus (Author ID: 55321350600), reflecting his strong academic impact. His studies emphasize innovative predictive and prognostic modeling approaches, such as exploring the fibrinogen-to-albumin ratio, red cell distribution width, and lymphocyte-to-monocyte ratio as novel indicators of adverse cardiovascular events and renal complications. Beyond his research, he has supervised postgraduate theses on cardiovascular risk assessment, contributed to collaborative projects in clinical and translational cardiology, and serves as Editor of the Ege Klinikleri Tıp Dergisi. As an active reviewer for several international cardiology journals, Dr. Tuncay Kırış continues to advance evidence-based cardiology through data-driven research, bridging clinical practice with innovation to improve patient outcomes and global cardiovascular health.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  • Yildirim, S. E., Yildirim, T., Kırış, T., & Avci, E. (2025, October). Prognostic value of the NAPLES score and serum uric acid in chronic coronary syndrome: Evidence from time-dependent ROC and time-varying hazard ratio analyses. Journal of Clinical Medicine, 14(20), 7416. https://doi.org/10.3390/jcm14207416

  • Tiryaki, M. M., Yılmaz, C., Ince, H. S., Karaca, B., Kayaalti Esin, F., & Kırış, T. (2025, September). Neutrophil percentage-to-albumin ratio as a predictor of in-hospital mortality in infective endocarditis. Biomarkers in Medicine, 19(17), 1–8. https://doi.org/10.1080/17520363.2025.2562554

  • Akkan, G., Kırış, T., Esin, F., & Karaca, M. (2025, May). Evaluation of mortality and hospitalization due to decompensated heart failure and appropriate shocks in reduced ejection fraction in patients with an implantable cardioverter–defibrillator according to a novel tissue Doppler echocardiographic method. Journal of Clinical Medicine, 14(9), 3226. https://doi.org/10.3390/jcm14093226

  • Esin, F., Bozkurt, H., Palac, B., Akar, B., Kırış, T., Özdemir, E., & Karaca, M. (2025, February). The impact of pleural effusion on long-term mortality in patients undergoing transcatheter aortic valve implantation. Journal of Clinical Medicine, 14(5), 1596. https://doi.org/10.3390/jcm14051596

  • Usta, A., Sancakli Usta, C., Lafci, D., Kırış, T., & Avci, E. (2024, December). Contrast induced nephropathy in women with infertility undergoing hysterosalpingography. Reproductive Biology and Endocrinology, 22(1). https://doi.org/10.1186/s12958-024-01334-3